MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Correlates of gait impairment in parkinson’s disease

    E. Abdeldayem, A. Shalash (Cairo, Egypt)

    Objective: Assess gait dysfunction in patients with PD and its correlation with clinical (motor and non-motor symptoms) and radiological findings. Background: Gait impairment is one…
  • 2023 International Congress

    Supra-ON state freezing of gait: The unpredictable response to levodopa in Parkinson´s Disease

    M. Magriço, V. Ferreira, B. Meira, R. Barbosa (Lisboa, Portugal)

    Objective: To discuss the therapeutic dilemma of freezing in supra ON Background: Freezing of gait (FOG) is a common manifestation of Parkinson's disease (PD), occurring…
  • 2023 International Congress

    Palliative Care in Parkinson: a family caregiver’s view. A PD-PAL Consortium initiative.

    D. Trivedi, M. Qamar, V. Leta, M. Meinders, C. Münte, M. Groot, A. Antonini, M. Garon, K. Ray Chaudhuri (London, United Kingdom)

    Objective: We aim to identify clinical indicators and markers for timely referral, access, and need of PC in our PwP community, from the viewpoint of…
  • 2023 International Congress

    The study of genetic factors in levodopa-induced motor complications development in Russian patients with Parkinson’s disease

    G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, S. Umutbaev, R. Galimova, A. Baitimerov, R. Magzhanov (Ufa, Russian Federation)

    Objective: This study is aimed to explore the relationship between the single nucleotide polymorphisms (SNPs) in dopamine and serotonin metabolism genes, other neurotransmitter systems genes…
  • 2023 International Congress

    Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease

    A. Regalado Mustafá, D. Aguila Godinez, A. Herrera Ruiz, E. Santiago-de-La-Cruz, L. Lira Juárez, M. Medrano Delgado, M. Ruiz Mafud, A. Hernández-Medrano, D. Romero-Terán, M. Medina-Pérez, G. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Domínguez García, J. García Hernández, A. Alcocer Salas, K. Talavera Lagunas (Mexico City, Mexico)

    Objective: Investigate the relationship between the dose of dopamine replacement therapy (DRT) and pain severity as measured by the King's Parkinson's Disease Pain Scale (KPPS)…
  • 2023 International Congress

    The effect of APOE ε4 on striatal vesicular monoamine transporter-2 density in Parkinson’s disease

    W. Li, R. Li, J. Lu (Beijing, China)

    Objective: To evaluate the effect of apolipoprotein E 4 (APOE 4) on striatal vesicular monoamine transporter-2 (VMAT2) density in Parkinson’s disease (PD).To evaluate the effect…
  • 2023 International Congress

    Evaluation of neuroprotective role of carvacrol via Nrf2-NLRP3 axis in rotenone induced PD mice model

    D. Khatri, S. Shah, K. Tryphena (Hyderabad, India)

    Objective: To explore the antioxidant and anti-inflammatory role of Carvacrol via Nrf2-NLRP3 axis in rotenone induced PD mice model Background: NLRP3 inflammasome mediated neuroinflammation is…
  • 2023 International Congress

    Relationship between balance performance and corticomotor Inhibition in individuals with Parkinson’s disease

    HH. Liu, YR. Yang, YL. Ling, RY. Wang, SJ. Cheng (Taipei City, Taiwan)

    Objective: To explore the possible relationship between corticomotor inhibition assessed by transcranial magnetic stimulation (TMS) and balance performance in individuals with Parkinson’s disease (PD). Also,…
  • 2023 International Congress

    Early cortical atrophy is related to depression in Parkinson’s disease

    E. Backman, L. Saari, R. Parkkola, J. Lötjönen, M. Gardberg, V. Kaasinen (Turku, Finland)

    Objective: To investigate depression in relation to medial temporal lobe atrophy (MTA), global cortical atrophy (GCA) and white matter hyperintensities (WMH) in neuropathologically confirmed patients…
  • 2023 International Congress

    Supine hypertension is longitudinally associated with cognitive decline in Parkinson disease independent of orthostatic hypotension

    C. Miller-Patterson, J. Hsu, M. Barrett, L. Cloud, T. Chelimsky (Richmond, USA)

    Objective: To determine whether orthostatic hypotension (OH) and/or supine hypertension (SH) are longitudinally associated with cognitive decline in Parkinson disease (PD). Background: Cognitive impairment is…
  • « Previous Page
  • 1
  • …
  • 402
  • 403
  • 404
  • 405
  • 406
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley